- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04846153
Comparing Human and Computer-based Quantification of Airway Stenosis From Bronchoscopic Images
April 14, 2021 updated by: Nobuhiko Hata, PhD, Brigham and Women's Hospital
This is a pilot study to assess the utility of the automatic stenosis index quantification using 3D Slicer software (Computer-based Quantification).
We will recruit three physicians to perform a similar analysis using video images of the same bronchoscopes images (Human-based Quantification).
This study relates to the latter data collection.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
3
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nobuhiko Hata, PhD
- Phone Number: 617-732-5809
- Email: hata@bwh.harvard.edu
Study Contact Backup
- Name: Artur Banach, MRes
- Email: abanach@bwh.harvard.edu
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Physicians who are trained in bronchoscopy.
- Physicians who are willing and able to understand the scope of the study.
Exclusion Criteria:
- Physicians who are not trained in bronchoscopy.
- Physicians who are unwilling and unable to understand the study procedure
- Employees under the direct supervision of the investigators conducting the research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Human-based Quantification
No intervention.
No support tool will be used for quantifying airway stenosis from the bronchoscopic images collected previously.
|
Human-based Quantification of Airway Stenosis From Bronchoscopic Images.
|
Active Comparator: Computer-based Quantifiction
Computer based support tool will quantifying airway stenosis from the bronchoscopic images collected previously.
|
Computer-based Quantification of Airway Stenosis From Bronchoscopic Images.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stenosis index quantified [0-100%]
Time Frame: 1 year
|
The stenosis index quantified subjectively by the physician, defined ration between cross-sectional area of the obstructed airway and that of a normal airway.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 16, 2021
Primary Completion (Anticipated)
April 16, 2021
Study Completion (Anticipated)
July 16, 2021
Study Registration Dates
First Submitted
April 12, 2021
First Submitted That Met QC Criteria
April 14, 2021
First Posted (Actual)
April 15, 2021
Study Record Updates
Last Update Posted (Actual)
April 15, 2021
Last Update Submitted That Met QC Criteria
April 14, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AirwayStenosis2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Currently, there is no plan to share IPD.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Obstruction
-
Beth Israel Deaconess Medical CenterMedWaves, IncRecruitingAirway Obstruction | Central Airway ObstructionUnited States
-
McMurray Medical Group, LLCCompletedUpper Airway ObstructionUnited States
-
Massachusetts General HospitalCompletedUpper Airway ObstructionUnited States
-
Rigshospitalet, DenmarkCompletedUpper Airway ObstructionDenmark
-
Zhongda HospitalUnknownMalignant Airway ObstructionChina
-
Assistance Publique - Hôpitaux de ParisRecruitingRespiratory Distress | Upper Airway ObstructionFrance
-
ResMedCompletedRespiratory Failure | Respiratory Insufficiency | Upper Airway ObstructionUnited States
-
Massachusetts General HospitalCompletedMechanical Ventilation Complication | Upper Airway ObstructionUnited States
-
Aerin MedicalOhio State UniversityCompletedNasal ObstructionUnited States
-
University of RochesterCompletedUpper Airway ObstructionUnited States
Clinical Trials on Human-based Quantification of Airway Stenosis
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; Johns Hopkins University; University... and other collaboratorsCompletedIdiopathic Subglottic Stenosis (iSGS)United States, Australia, Iceland, United Kingdom
-
Origin SciencesRoyal Infirmary of EdinburghRecruitingDiagnosis | Vagina DiseaseUnited Kingdom
-
Elin TragardhLund UniversityRecruiting
-
Ondokuz Mayıs UniversityCompletedSpirituality | Palliative Care | HopeTurkey
-
Akdeniz UniversityCompletedQuality of Life | Satisfaction, Patient | Renal Disease | Adherence, TreatmentTurkey
-
IVI MadridTerminated
-
Massachusetts General HospitalWithdrawnEndometrial Mixed Cell Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Cytoreductive Surgery | High Grade Serous Carcinoma | Grade 3 Endometrial Endometrioid AdenocarcinomaUnited States
-
Glaxo WellcomeCompletedHIV InfectionsUnited States
-
Vital Therapies, Inc.TerminatedSevere Acute Alcoholic HepatitisUnited States, Spain, United Kingdom, Germany